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Цель. изучить результаты хирургического лечения пациентов с аорто-подвздошной патологией в 
раннем послеоперационном периоде.
Материал и методы. в исследование включено 103 пациента с аортальной патологией, которые 
были направлены в клинику сосудистой хирургии с 2015 по 2017 год. прооперировано 53 пациента с 
аорто-подвздошным атеросклерозом и 50 пациентов с аневризмой абдоминальной аорты. показанием к 
операции были перемежающаяся хромота, критическая ишемия конечности или острый тромбоз аорты у 
пациентов с аорто-подвздошным атеросклерозом. показанием к операции у пациентов с аневризмой аб-
доминальной аорты была аневризма более 5,5 см в поперечном диаметре или разрыв аневризмы. ранние 
результаты хирургического лечения пациентов оценивали по частоте послеоперационных осложнений и 
летальных исходов.
Результаты. из 53 пациентов с аорто-подвздошным атеросклерозом 49 (92,5%) пациентов были 
прооперированы в плановом порядке и 4 (7,5%) пациента были прооперированы ургентно. выполнено 52 
(98,2%) аорто-бифеморальных шунтирования и один (1,8%) аорто-феморальный (односторонний) шунт. 
три осложнения (6,1%) наблюдались у пациентов, которые были прооперированы в плановом порядке, и 
одно осложнение (25%) у пациента, которого оперировали в ургентном порядке. среди ургентных пациен-
тов смертность составила 25%, среди плановых – 2,0%. прооперированы 28 пациентов с бессимптомной 
аневризмой абдоминальной аорты и 22 пациента с разрывом аневризмы абдоминальной аорты. смерт-
ность после плановой операции составила 3,6%. у пациентов с разрывом аневризмы абдоминальной аорты 
смертность составила 40,9%.
Заключение. хорошие и удовлетворительные результаты планового хирургического лечения сим-
птоматического аорто-подвздошного атеросклероза в раннем послеоперационном периоде составили 98%, 
асимптоматической аневризмы аорты – 96,4%. смертность после ургентной операции при разрыве анев-
ризмы составила 40,9%. хирургическое лечение аневризмы аорты показано у пациентов с низким и сред-
ним хирургическим риском.
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Objective. To investigate the results of surgical treatment of patients with aortoiliac pathology in the early 
postoperative period.
Methods. In the study 103 patients with aortoiliac pathology were included, who were referred to the Clinic 
of Vascular Surgery from 2015 to 2017 years. 53 patients were operated on because of aortoiliac atherosclerosis and 
50 patients – because of abdominal aortic aneurysm. The indications for surgery were limiting claudication, critical 
limb ischemia or acute thrombosis of the aorta in patients with aortoiliac atherosclerosis. The indication for surgery 
in patients with abdominal aortic aneurysm was the aneurysm over 5.5 cm in the transverse diameter or the ruptured 
aneurysm. Early results of patients’ surgical treatment were assessed by the frequency of postoperative complications 
and deaths.
Results. 49 (92.5%) out of 53 patients with aortoiliac atherosclerosis were operated on as planned and 
4 (7.5%) patients were operated on urgently. 52 (98.2%) aortobifemoral bypasses and one (1.8%) aortofemoral 
(unilateral) bypass were performed. Three complications (6.1%) occurred postoperatively in patients operated on 
according to plan and one complication (25%) – in patients operated urgently. The mortality rate was 25% in urgent 
patients and 2.0% in planned patients. 28 patients with asymptomatic abdominal aortic aneurysm and 22 with the 
ruptured abdominal aortic aneurysm were operated on. The mortality in the planned patients was 3.6%. 40.9% 
mortality rate was registered in the ruptured abdominal aortic aneurysm patients.
Conclusions. Early good and satisfactory results of the routine surgical treatment of symptomatic aortoiliac 
atherosclerosis in the early postoperative period accounted 98%, asymptomatic aortic aneurysm – 96.4%. Mortality 
after urgent surgery with aneurysm rupture made up 40.9%. Surgical treatment of aortic aneurysm is indicated in 
patients with low and moderate surgical risk.
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Научная новизна статьи
установлено, что смертность плановой открытой аортальной операции при абдоминальных аневризмах 
составляет около 3,6%, смертность при разрыве аневризмы достигает 40,9%.
What this paper adds
It has been established that the mortality rate of the planned open aortic surgery for abdominal aneurysms is about 
3.6%, the mortality rate after the rupture of the aneurysm reaches 40.9%.
Introduction
Aortoiliac reconstruction represents the 
possibilities of surgical treatment of atherosclerosis, 
both obliterating disease and aortoiliac aneurysm. 
The first aortoiliac reconstruction was performed 
by Wylie in the USA, who in 1951 did aortic 
bifurcation thrombendarterectomy in atherosclerotic 
obliteration [1]. The first reconstruction of an aortic 
aneurysm was carried out by Dubost in Paris in 
1951. He restored continuity after resection of the 
aortic aneurysm rupture using a preserved human 
aortic graft [1]. But the further development of 
the aortoiliac reconstruction was impossible due 
to the lack of aortic allografts, which represented 
the only possibility of restoring aortic continuity. 
The golden era of aortoiliac reconstructions began 
with the invention of aortic-bifemoral shunts [2]. 
The introduction of endovascular treatment of 
aortic pathologies was the second important factor 
that changed the possibilities of treatment. At 
the beginning of our millennium, the widespread 
development of interventional procedures changed 
the approach to the treatment of aortoiliac 
pathology. Aortoiliac reconstruction is performed 
as a surgical treatment of aortoiliac atherosclerosis, 
which cannot be treated endovascularly, mainly to 
TASC D patients, according to the TASC (Trans-
Atlantic Inter-Society Consensus) classification [3]. 
Surgical treatment of abdominal aortic aneurysm 
(AAA) is indicated for asymptomatic treatment in 
patients with aneurysms with the diameter of more 
than 5.5 cm in cross section or in the rupture of 
AAA [4]. 
According to the updated AAA treatment 
guidelines, according to the European Society 
of Vascular Surgery (ESVS) from 2019, surgical 
treatment is an option for patients with a life 
expectancy of more than 10-15 years. Routine 
AAA surgery is not recommended for patients with 
terminal cancer, patients with severe heart failure 
and a life expectancy of less than 2–3 years. [5, 6].
Objective. To investigate the results of surgical 
treatment of patients with aortoiliac pathology in 
the early postoperative period.
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Methods
The study was conducted in the Clinic of 
Vascular Surgery of Eastern Slovak Institute of 
Cardiovascular Diseases, Kosice, Slovakia. A 
retrospective study included 103 patients with 
aortoiliac pathology who were referred to the 
department from January 2015 to December 2017. 
53 patients with aortoiliac atherosclerosis and 50 
patients with AAA were operated on. Indications for 
surgery were intermittent claudication, critical limb 
ischemia or acute aortic thrombosis in patients with 
aortoiliac atherosclerosis. The diagnosis of aortoiliac 
atherosclerosis was based on CT angiography or 
angiography. Indications for surgery were exposed 
to patients with AAA more than 5.5 cm in transverse 
diameter and all patients with the aneurysm 
rupture. The diagnosis of AAA was established using 
ultrasound and CT angiography.
Results
Aortoiliac atherosclerosis. 49 (92.5%) out of 53 
patients with aortoiliac atherosclerosis were operated 
on in the planned manner and 4 (7.5%) patients 
were operated urgently (Table 1).
52 (98.2%) aortic-bifemoral bypass operations 
and one (1.8%) aortic-femoral (one-sided) shunting 
to the right due to the superimposed sigmostomy 
were performed. Aortic-bifemoral bypass was 
performed using a Dacron prosthesis, the proximal 
anastomosis was standardized by the side-to-end 
principle. Distal anastomoses were placed in the 
common femoral artery with the continuation of the 
anastomosis to the end-to-side deep femoral artery.
Additional interventions of aortic-bifemoral 
bypass were: AAA resection with the end-to-end 
anastomosis in 2 patients, aortic thrombectomy in 8 
patients due to subrenal aortic thrombosis, and in one 
patient the lower mesenteric artery was re-implanted 
to prevent left ischemic ischemia (Table 2).
There were four complications requiring 
reoperation after aortic reconstruction: three 
complications (6.1%) occurred in patients who 
were operated on in a planned manner (bleeding 
in one patient and prosthetic thrombosis in two 
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patients); one complication (25%) requiring surgical 
intervention in a patient (prosthetic thrombosis), 
which was operated on urgently (Table 3)
One patient died (25%) of all urgent patients 
in the postoperative period; and one patient died 
operated on in a planned manner (2.0%).
Aneurysm of the abdominal aorta. 28 surgical 
interventions for asymptomatic AAA were performed. 
Aortic shunting was performed in 15 patients using 
the dacron prosthesis when the iliac arteries were not 
involved in the aneurysm process. In 13 cases, aortic-
bifemoral bypass was performed, when the common 
iliac arteries were expanded by more than 2.5 cm. 
In cases of aortic-bifemoral bypass, the proximal 
anastomosis was done end-to-end, and the distal – 
end-to-side. In the case of aorto-aortic prosthesis, 
the proximal and distal anastomoses were performed 
end-to-end. Aortic-bifemoral bypass was performed 
using the dacron prosthesis, the distal anastomoses 
were sutured into the common femoral artery with the 
continuation of the anastomosis to the deep femoral 
artery. The lower mesenteric artery was reimplanted 
into the prosthesis in four patients (Fig. 1).
Reimplantation was performed to prevent 
ischemia of the left colon, when both internal iliac 
arteries were transfected and ligated during the 
surgery. One patient died after the planned surgery; 
the mortality rate was 3.6%. (Table 4).
22 patients were operated on due to rupture 
of AAA. Eleven aorto-aortic reconstructions, 9 
aortic-bifemoral reconstructions, and 2 explorative 
laparotomies were performed when patients died 
during the surgical resuscitation. In one patient 
with suprarenal AAA, it became necessary to 
reimplant both renal arteries. Eight patients (36%) 
needed reoperations: three due to acute limb 
ischemia, two due to postoperative bleeding, one 
due to perforation of peptic ulcer, one due to acute 
coronary syndrome and one due to infection after 
laparotomy (Table 5). Nine patients (40.9%) died 
in the postoperative period after urgent surgery.
Table 1
Aortoiliac reconstructions carried out in the department for 2015-2017
Table 2
Additional interventions for aortobifemoral bypass. Aneurysm of the abdominal aorta
Table 3
Complications requiring surgery
Diagnosis Number %
Aortoiliac atherosclerosis – planned 49 47.6%
Aortoiliac atherosclerosis – urgent 4 3.9%
Abdominal aortic aneurism (planned) 28 27.2%
Abdominal aortic aneurysm rupture 22 21.4%
All patients 103 100%
Additional interventions Number %
Additional interventions in aortic-bifemoral bypass 53 100%
Abdominal aortic aneurysm resection and end-to-end anastomosis 2 3.8%
Subrenal aortic thrombectomy 8 15.1%
Reimplantation of the inferior  mesenteric artery 1 1.8%
Planned operations 49 92.5%
Urgent operations 4 7.5%
Complications Number %
Bleeding 1 2%
Thrombosis of limb arteries 2 4.1%
Planned surgeries 3 6.1%
Shunt thrombosis – acute 1 25%
Urgent surgeries 1 25%
Total 4 8.1%
Fig. Reimplantation of the inferior mesenteric artery.
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Discussions
Aortoiliac reconstructions are performed 
mainly in atherosclerosis or aneurysm of the aorta 
and aortoiliac segment. Surgeries are indicated for 
patients with TASC C or TASC D lesions according 
to the TASC classification [3]. Aortic-bifemoral 
bypass is the “gold standard” for the treatment 
of symptomatic aortoiliac atherosclerosis. There 
are two possible access to the abdominal aorta: 
transperitoneal and retroperitoneal, both acceptable 
and have similar results [1]. Aortic reconstructions 
are performed mainly with the prosthesis “Dacron”. 
It is preferable that the proximal aorta anastomosis 
is designed side-to-end, which is technically not 
so difficult, and also allows for blood flow to the 
lumbar and pelvic arteries and, therefore, prevents 
pelvic ischemia [2]. The end-to-end anastomosis is 
appropriate in cases of AAA or in the case of very 
common aortic atherosclerosis, when only a small 
portion of the subrenal aorta is soft [7]. In such 
situations, the proximal anastomosis is performed on 
the cross-clamping aorta. In our group of patients, 
we performed the end-to-end anastomosis in only 
two (3.8%) patients who had AAA. In one patient, we 
reimplanted the inferior mesenteric artery to prevent 
ischemia of the left colon. The distal anastomosis 
should be placed on the common femoral artery 
with the continuation of the anastomosis on the 
deep femoral artery to prevent the stenosis of the 
latter in future. Stenosis of the deep femoral artery 
can lead to limb thrombosis. Profundoplasty plays 
an important role in maintaining the long-term 
patency of aortic-bifemoral bypass operations [8]. 
Aortic-bifemoral bypass is a safe procedure with a 
very low mortality rate, up to 2% and a 10-year 
patency of 75-85% [7]. In the presented patients, 
the complication rate in planned cases was 6.1%, 
mortality - 2.0%. The level of complications 
and mortality in urgent patients were higher: the 
complication rate was 25% and the mortality rate 
was 25% among urgent patients. One patient had 
the prosthesis thrombosis and one patient died in 
the postoperative period. Thus, it is important to 
carry out surgical interventions in patients at the 
stage of a stable course of the disease and to prevent 
acute occlusion in which there is a high mortality 
rate of up to 22% [8]. About 60% of patients with 
aortoiliac atherosclerosis also have peripheral artery 
disease [9]. In 80% of patients with aortoiliac and 
femoral atherosclerosis, the symptoms of ischemia 
are reduced after aortic-bifemoral bypass surgery, 
and only 20% of them require reconstruction of 
the femoral-popliteal arterial segment after aortic-
bifemoral bypass [5]. Taking into consideration 
these excellent long-term indices of patency, aortic-
bifemoral bypass is currently considered the method 
of choice for revascularization [2].
Another possibility of aortoiliac reconstructions 
is aortic endarterectomy. Despite this procedure 
was the first aortoiliac reconstruction, it is not 
commonly used today. The only advantage of 
endarterectomy compared with aorto-bifemoral 
bypass is the absence of prosthetic material, but 
the endarterectomy has been replaced by bypass 
operations [6].
Another possibility to manage aortoiliac 
atherosclerosis is to perform revascularization of 
Table 4
Surgical interventions and complications of asymptomatic abdominal aortic aneurysm
Table 5
Surgical interventions and complications in rupture of the abdominal aortic aneurysm
Aortic reconstruction Number %
Aorto-aortic prosthesis 15 54%
Aortic-bifemoral bypass 13 46%
Repeated implantation of the inferior  mesenteric artery 4 14.2%
Total 28 100%
Complications requiring reoperation
Bleeding 2 7.1%
Complications in the groin area 1 3.6%
Infection 1 3.6%
Total complications 4 14.2%
Mortality 1 3.6%
Aortic reconstructions 22 100%
Aorto-aortic prosthesis 11 50%
Aortic-bifemoral bypass 9 41%
Expiratory laparotomy 2 9%
Repeated implantation of the renal arteries 1 4.5%
Mortality 9 40.9%
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one iliac artery, either endovascularly or surgically, 
and then apply an extraanatomical femoro-femoral 
bypass. Cross-shunting has a lower long-term 
patency compared with aortic-bifemoral bypass, but 
does not require laparotomy, so it is intended for 
polymorbid patients who are not suitable for aortic 
surgery. The five-year patency of femoro-femoral 
bypass is about 70% [9]. But in patients with low and 
moderate surgical risk, we prefer aortic-bifemoral 
bypass.
Aneurysms of the abdominal aorta are 
indications for surgeries in cases where the 
transverse diameter exceeds 55 mm, when 
aneurysmal expansion of more than 10 mm occurs 
in one year or in case of a rupture [10]. The 
diagnosis of AAA is based on CT angiography. CT 
angiography accurately determines the proximal 
and distal part of AAA, more accurately depicts the 
iliac arteries and provides important information 
for the operation planning. This is especially true 
for modern multi-detector spiral CT with thin 
sections in the place of interest [6]. Ultrasound is 
suitable as a screening method, but not as a final 
diagnostic method in patients with AAA for the 
planned surgery. However, ultrasound is the key 
method in unstable AAA rupture patients, which 
should be used immediately, since CT angiography 
can lead to delay, intra-abdominal rupture and 
patient’s death [4].
Both approaches  o f  surg ica l  acces s 
(transperitoneal and retroperitoneal) can be used 
during aortic surgery. The choice of surgical access 
should be determined by the preference of the 
surgeon and his qualifications [11]. If the aortic 
aneurysm does not extend to the iliac arteries, 
end-to-end aorto-aortic prosthesis is performed. 
In cases of aneurysm of the iliac arteries, aortoiliac 
or aorto-bifemoral bypass surgery should be 
performed. The indication for the reconstruction 
of ileal aneurysm is its diameter of more than 2.5 
cm with concomitant aortic surgery or 3.5 cm with 
an isolated reconstruction of the iliac aneurysm. 
[1, 12]. Aortoiliac reconstruction is preferred for 
comorbidities, due to the absence of inguinal 
incisions. We have good experience of aortic-
bifemoral bypass in cases of concomitant aortic 
and iliac aneurysms. Anastomosis in the common 
femoral artery is not as technically complex as the 
end-to-end anastomosis in the iliac arteries in the 
pelvic region, especially in obese men or when 
aneurysm ruptures. Early mortality after open 
surgery on aneurysms ranges from 5% to 8% [6]. In 
the presented material, the mortality after planned 
surgery of aortic aneurysm was 3.6%. Perioperative 
complications were observed in 14.6% of patients 
who were operated on as planned patients.
Recently, a higher increase in endovascular 
interventions has been registered, resulting in 
the fact that up to 60% of planned AAA cases 
in the USA are being treated with endovascular 
methods and the open surgical method is reserved 
for patients with anatomy that is not suitable for 
EVAR (EndoVascular Aneurysm Repair) [13]. But 
recent results from randomized controlled studies of 
EVAR-1 and EVAR-2, after 15 years, have shown 
that EVAR does not exceed open reconstruction. 
EVAR has a better early survival rate, but inferior 
in late survival compared with open operations [5]. 
EVAR also has a higher rate of reintervention than 
open surgery. In general, the frequency of repeated 
interventions with aneurysm was higher in the 
EVAR group than in the group of open operations: 
4.1 and 1.7 per 100 person-years, respectively (p 
<0.001), with repeated interventions occurring 
during the observation [14].
Open AAA operations are indicated for patients 
with low and moderate surgical risk, and EVAR 
should be considered in patients with high surgical 
risk or in patients after multiple abdominal surgeries 
[6]. Results obtained for over 15 years of observation 
suggest that EVAR does not prolong life in patients 
unsuitable for open surgery [14].
Mortality in the reconstruction of AAA rupture 
is up to 50.8%. Aortic rupture leads to a combination 
of reperfusion injuries, hemorrhagic shock, lower 
trunk ischemia and multiorgan failure [11]. In the 
examined group of patients, the mortality after 
urgent surgery for the aneurysm rupture was 40.9%.
The only randomized study that assessed death 
and severe complications of AAA rupture was the 
Dutch multicenter randomized study (AJAX). AJAX 
results show that death and severe complications 
occur in 21% of patients after EVAR and in 25% 
after open repair of the AAA rupture, as is evident, 
there is no significant difference [15]. In patients 
with rupture of the abdominal aortic aneurysm, 
EVAR may be useful in case of appropriate anatomy 
for endovascular treatment.
Conclusions
Good and satisfactory results of planned surgical 
treatment of symptomatic aortoiliac atherosclerosis 
in the early postoperative period amounted up 
to 98%, asymptomatic aortic aneurysm - 96.4%. 
Mortality after urgent surgery with the aneurysm 
rupture was 40.9%. Surgical treatment of aortic 
aneurysm is indicated in patients with low and 
moderate surgical risk.
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